| Literature DB >> 20098705 |
Remo Frei1, Johanna Steinle, Thomas Birchler, Susanne Loeliger, Caroline Roduit, Dirk Steinhoff, Reinhart Seibl, Katja Büchner, Reinhard Seger, Walter Reith, Roger P Lauener.
Abstract
BACKGROUND: Major histocompatibility complex (MHC) class II molecules play crucial roles in immune activation by presenting foreign peptides to antigen-specific T helper cells and thereby inducing adaptive immune responses. Although adaptive immunity is a highly effective defense system, it takes several days to become fully operational and needs to be triggered by danger-signals generated during the preceding innate immune response. Here we show that MHC class II molecules synergize with Toll-like receptor (TLR) 2 and TLR4 in inducing an innate immune response. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2010 PMID: 20098705 PMCID: PMC2808354 DOI: 10.1371/journal.pone.0008808
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Expression of HLA-DR enhances TLR2 and TLR4 dependent activation of HEK293 cells.
(A, B) Co-expression of HLA-DR in TLR2+ or TLR4+ HEK293 cells leads to enhanced hBD-2 expression (n≥3) after stimulation with BLP and LPS, respectively (black bars) compared to untreated cells (grey bars). (C) Co-expression of HLA-DR in TLR7+ cells did not increase the TNF expression (n = 3) after treatment with Loxoribine (black bars) compared to untreated cells (grey bars). (D) Co-expression of HLA-DR lacking the intracellular part in TLR2+ HEK293 cells failed to enhance hBD-2 expression after stimulation with BLP (n = 3). Error bars represent standard errors; * p<0.05, ** p = 0.055.
Figure 2Peritoneal macrophages from MHC class II knock-out mice show impaired responsiveness to BLP and LPS.
(A–E) Cytokine secretion of peritoneal macrophages from MHC class II knock-out mice (grey bars; n≥4) is reduced compared to wild-type control mice (black bars; n≥3) after ex vivo stimulation with BLP and LPS. Error bars represent standard errors; ** p = 0.053, * p<0.05.
Figure 3TLR2 and HLA-DR interact physically in lipid raft domains.
(A) Co-precipitation of labeled recombinant TLR2 (lane 1, 3, 4) or a control protein (lane 2, luciferase) with HLA-DR molecules purified by immunoprecipitation with anti HLA-DR antibodies (lane 1, 2, 4) or control antibodies (lane 3) from cell lysates of HLA-DR positive (lane 1, 2, 3) or negative (lane 4) HEK293 cells. A 14C-labeled molecular weight marker (in kD) is shown in the left lane. (B) Proximity ligation assays showed that TLR2 and HLA-DR are close together (red signal), while TLR2 and HLA-ABC do not co-localize (no red signal). Nuclei are stained by Hoechst 33342 (blue). (C) Treatment of TLR2+ (grey bars; n = 3) or HLA-DR+/TLR2+ (black bars; n = 3) HEK293 cells with MCD, a lipid raft-destroying agent, prior to stimulation with BLP leads to impaired hBD-2 gene expression. The effect is restored via adding MCD saturated with cholesterol acting as cholesterol donor. Error bars represent standard errors. (D) Immunofluorescence microscopy showed that TLR2 (αTLR2-FITC; green) and HLA-DR (αHLA-DR-APC-Cy9; blue) co-localize in lipid raft domains (CT-rhodamine; red) of HLA-DR+/TLR2+ HEK293 cells (indicated by the white arrows). Pictures are representatives of at least five experiments.